Key facts
- This page summarizes David Hung's Form 4 filing for Nuvation Bio Inc. (NUVB).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 18 Jun 2025, 16:05.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Purchase
Additional SEC filing notes
Footnote F1
) The price reported is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $1.64 to $1.88, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price.